NASDAQ:APM
Aptorum Group Limited Class A Stock News
$4.75
-0.350 (-6.86%)
At Close: May 17, 2024
Stocks To Watch: Jobs Report, Virtual Conferences And Blue Chips On Tap
01:09pm, Saturday, 02'nd May 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Aptorum Group Limited to Present at the Infectious Disease Virtual Conference
12:00pm, Wednesday, 29'th Apr 2020
Aptorum Group Limited (Nasdaq:APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, including orphan diseases, inf
Instana Announces Integration with Coralogix Log Analytics Solution
03:30pm, Thursday, 23'rd Apr 2020
Instana, the leading provider of real-time application performance management(APM) solutions for cloud-native microservice applications, today announced the availability of one-click integration with
New Relic Announces The General Availability Of AIOps Platform
04:38pm, Sunday, 19'th Apr 2020
By expanding the portfolio to observability and AIOps, New Relic aims to go beyond traditional APM and infrastructure monitoring to strengthen its position in the emerging market predominantly driven
Aptorum Group Ltd (NASDAQ:APM) Sees Significant Growth in Short Interest
08:44am, Saturday, 18'th Apr 2020
Aptorum Group Ltd (NASDAQ:APM) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 19,900 shares, a growth of 7.0% from the March 15th tot
Aptorum Group Limited to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020
12:00pm, Wednesday, 15'th Apr 2020
NEW YORK, NY / ACCESSWIRE / April 15, 2020 / Aptorum Group Limited (NASDAQ:APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global ...
Solebury Trout Announces Additional Virtual Conference Presentations from Life Science Companies on April 7, 2020
07:15pm, Monday, 06'th Apr 2020
NEW YORK, NY / ACCESSWIRE / April 6, 2020 / Solebury Trout, a boutique investor relations and corporate communications firm, announced today that it will be hosting a fourth day of presentations as pa
（ビジネスワイヤ） -- 感染症・希少疾患・代謝性疾患などの領域における未充足ニーズに対処するための新規治療薬の開発に傾注するバイオ製薬企�
Az Aptorum Csoport egyttműkdik a Covar Pharmaceuticals-zel
12:45pm, Tuesday, 31'st Mar 2020
Az Aptorum Csoport együttműködik a Covar Pharmaceuticals-zel legalább 3 újrapozicionált gyógyszerjelölt (SACT-COV19) koronavírus betegség 2019 (COVID-
Aptorum Group Limited (Nasdaq: APM) (
Firma Aptorum Group Limited (index Nasdaq: APM) (dále jen
知臨集團與Covar醫療攜手透過現有Smart-ACT™平臺和Acticule傳染病平臺研究至少3種2019冠狀病毒肺炎(COVID-19)候選再利用藥物（SACT-COV19）
06:45am, Tuesday, 31'st Mar 2020
(美國商業資訊) -- 致力於開發創新療法以解決傳染病、孤兒病及代謝性疾病等全球未被滿足的醫療需求的生物製藥公司知臨集團（那斯達克股票代碼：AP
Aptorum Group Limited (Nasdaq: APM) ('Aptorum Group'), een biofarmaceutisch bedrijf dat zich richt op de ontwikkeling van nieuwe therapieën voor onver
Aptorum Group e Covar Pharmaceuticals collaborano nell'ambito dello studio di almeno 3 candidati farmaci (SACT-COV19) riposizionati contro la malatt
Aptorum Group Coopera com Covar Pharmaceuticals para Pesquisar ao menos 3 Candidatos a Medicamentos Reaproveitados (SACT-COV19) para Doença do Coron
